![]() Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2000 | Founding Date 1921 | Founding Date 1978 | Founding Date 1993 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Wrocław, PL HQ Allschwil, CH | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Cambridge, US HQ |
Employees | Employees 88 | Employees 82517% decrease | Employees 1,685 | Employees 16,5612% increase | Employees 1,6441% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit N/A |
Net income | Net income N/A | Net income €162.2m (FY, 2024) | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income N/A |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyPLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyTakeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View company